Use of a donor‐derived cell‐free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection
- 27 March 2022
- journal article
- research article
- Published by Wiley in Pediatric Transplantation
- Vol. 26 (4) , e14258
Abstract
Background: Detection of donor‐derived cell‐free DNA (dd‐cfDNA) reliably identifies allograft rejection in pediatric and adult kidney transplant (KT) recipients. Here, we evaluate the utility of dd‐cfDNA for monitoring response to treatment among pediatric renal transplant recipients suffering graft rejection.Methods: 58 pediatric transplant recipients were enrolled between April 2018 and March 2020 and underwent initial dd‐cfDNA testing to monitor for rejection. Allograft biopsy was performed for dd‐cfDNA scores >1.0%. Patients with histologically proven rejection formed the study cohort and underwent appropriate treatment. Results of dd‐cfDNA, serum creatinine (SCr), biopsy findings, and treatment outcomes were evaluated. Standard statistical analyses were applied.Results: Nineteen of 58 (31%) patients had dd‐cfDNA score >1.0%, of which 18 (94.7%) had biopsy‐proven rejection. Median dd‐cfDNA value was 1.90% (interquartile range 1.43%–3.23%), and biopsy results showed 11 patients (61.1%) with antibody‐mediated rejection (AMR), 2 patients (11.1%) with T‐cell mediated rejection (TCMR), and 5 patients (27.7%) with mixed AMR/TCMR. SCr at time of biopsy was 1.28 ± 1.09 mg/dl. Following treatment, dd‐cfDNA scores decreased for all types of rejection but still remained >1.0% in both AMR (1.50% [0.90%–3.10%]) and mixed (1.40% [0.95%–4.15%]) groups. Repeat dd‐cfDNA values were <1.0% for patients with TCMR (0.20%–0.28%). SCr showed minimal change from pre‐treatment levels regardless of rejection subtype.Conclusions: Patients with TCMR may be reliably followed by dd‐cfDNA; however, it remains unclear whether persistently elevated dd‐cfDNA levels in AMR is a reflection of ongoing subclinical rejection or an inherent limitation of the assay's utility.Keywords
This publication has 40 references indexed in Scilit:
- OPTN/SRTR 2013 Annual Data Report: KidneyAmerican Journal of Transplantation, 2015
- Digital Droplet PCR for Rapid Quantification of Donor DNA in the Circulation of Transplant Recipients as a Potential Universal Biomarker of Graft InjuryClinical Chemistry, 2013
- Antibody-mediated vascular rejection of kidney allografts: a population-based studyThe Lancet, 2013
- Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney TransplantAmerican Journal of Transplantation, 2012
- Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and NonadherenceAmerican Journal of Transplantation, 2011
- Surveillance biopsies in children post-kidney transplantPediatric Nephrology, 2011
- Good outcome of kidney transplants in recipients of young donors: a NAPRTCS data analysisPediatric Transplantation, 2010
- KDIGO clinical practice guideline for the care of kidney transplant recipients: a summaryKidney International, 2010
- Protocol Biopsies in Renal Transplantation: Insights into Patient Management and PathogenesisAmerican Journal of Transplantation, 2007
- Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft LossAmerican Journal of Transplantation, 2006